Due to the lapse in government funding, the information on this web site may not be up to date, transactions submitted via the web site may not be processed,
and the agency may not be able to respond to inquiries until appropriations are enacted. Updates regarding government
operating status and resumption of normal operations can be found at opm.gov.
The Biodistribution of 1-[2 Deoxy-2, -18 Fluroarabinfuranosyl]Cytosine [18FAC] in Healthy Subjects and Patients With Cancer, Autoimmune/Inflammatory Diseases
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years and older (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
patients with cancer, autoimmune diseases and healthy subjects
> 18 years of age
women of childbearing potential will undergo a pregnancy test free of charge
patients with cancer or autoimmune diseases or healthy subjects
DE-PS02-08ER-08-01 ( Other Grant/Funding Number: Department of Energy )
CIRMNo. RT1-01126-1 ( Other Grant/Funding Number: California Institute for Regenerative Medicine )
10-000269 ( Other Identifier: UCLA Medical IRB#2 )